BSE Live
Jan 08, 16:01Prev. Close
404.20
Open Price
404.00
Bid Price (Qty.)
392.45 (2)
Offer Price (Qty.)
400.50 (200)
NSE Live
Jan 08, 15:59Prev. Close
404.00
Open Price
404.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
392.80 (178)
| Balance Sheet of Aarti Drugs (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 91.27 | 91.94 | 92.60 | 92.60 | 93.20 | |
| Total Share Capital | 91.27 | 91.94 | 92.60 | 92.60 | 93.20 | |
| Reserves and Surplus | 1,277.73 | 1,189.61 | 1,099.83 | 943.76 | 820.22 | |
| Total Reserves and Surplus | 1,277.73 | 1,189.61 | 1,099.83 | 943.76 | 820.22 | |
| Total Shareholders Funds | 1,369.00 | 1,281.55 | 1,192.43 | 1,036.36 | 913.42 | |
| Minority Interest | 0.34 | 0.41 | 0.23 | -0.06 | -0.02 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 284.00 | 275.33 | 204.68 | 138.50 | 147.56 | |
| Deferred Tax Liabilities [Net] | 78.23 | 75.71 | 70.97 | 72.43 | 77.13 | |
| Other Long Term Liabilities | 1.81 | 1.08 | 12.84 | 11.44 | 10.89 | |
| Long Term Provisions | 4.33 | 2.74 | 7.27 | 9.23 | 21.67 | |
| Total Non-Current Liabilities | 368.37 | 354.86 | 295.75 | 231.60 | 257.25 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 328.24 | 287.09 | 401.84 | 399.84 | 157.21 | |
| Trade Payables | 416.14 | 425.49 | 480.27 | 468.67 | 329.97 | |
| Other Current Liabilities | 88.29 | 80.01 | 46.50 | 67.83 | 105.38 | |
| Short Term Provisions | 4.29 | 2.95 | 4.37 | 3.71 | 2.80 | |
| Total Current Liabilities | 836.97 | 795.54 | 932.98 | 940.06 | 595.36 | |
| Total Capital And Liabilities | 2,574.68 | 2,432.36 | 2,421.40 | 2,207.96 | 1,766.01 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 858.96 | 809.91 | 675.43 | 689.78 | 665.14 | |
| Intangible Assets | 7.15 | 1.18 | 0.79 | 0.15 | 0.26 | |
| Capital Work-In-Progress | 274.15 | 225.23 | 210.35 | 76.74 | 19.26 | |
| Fixed Assets | 1,196.29 | 1,071.96 | 886.58 | 766.67 | 684.66 | |
| Non-Current Investments | 22.41 | 19.97 | 18.80 | 19.48 | 17.30 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-Current Assets | 17.62 | 19.70 | 23.67 | 28.44 | 7.26 | |
| Total Non-Current Assets | 1,236.32 | 1,111.64 | 929.05 | 814.59 | 709.22 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 472.93 | 485.89 | 516.29 | 525.94 | 415.00 | |
| Trade Receivables | 751.18 | 704.55 | 864.84 | 749.90 | 555.23 | |
| Cash And Cash Equivalents | 7.56 | 9.43 | 8.96 | 22.33 | 9.78 | |
| Short Term Loans And Advances | 0.76 | 0.24 | 0.00 | 0.00 | 0.00 | |
| OtherCurrentAssets | 105.93 | 120.61 | 102.26 | 95.20 | 76.79 | |
| Total Current Assets | 1,338.35 | 1,320.72 | 1,492.35 | 1,393.37 | 1,056.80 | |
| Total Assets | 2,574.68 | 2,432.36 | 2,421.40 | 2,207.96 | 1,766.01 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 306.94 | 281.02 | 262.94 | 211.49 | 155.67 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 87.02 | 87.02 | 87.02 | 87.02 | 87.59 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Non-Current Investments Unquoted Book Value | 22.41 | 19.97 | 18.80 | 19.48 | 17.30 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Current Investments Unquoted Book Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
14.11.2025
Aarti Drugs Consolidated September 2025 Net Sales at Rs 652.79 crore, up 9.1% Y-o-Y
12.11.2025
Aarti Drugs Standalone September 2025 Net Sales at Rs 578.95 crore, up 6.6% Y-o-Y
18.07.2025
Aarti Drugs Standalone June 2025 Net Sales at Rs 520.96 crore, up 5.68% Y-o-Y
18.07.2025
Aarti Drugs Consolidated June 2025 Net Sales at Rs 590.51 crore, up 6.33% Y-o-Y